Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

The U.S. Centers for Disease Control and Prevention lists several symptoms of prostate cancer, including difficulty starting urination, pain or burning during urination, blood in ...

One in two men aged 51–60 has BPH. The release states that an enlarged prostate is a non-cancerous condition where the prostate has grown to be larger than normal. If untreated, BPH could cause many ...

Discover a study where findings suggest that testosterone therapy can be safely administered to carefully selected men ...

The alpha blocker is typically prescribed to manage a nuisance symptom. Here's why the FDA says patients and healthcare ...

It’s about time your voice is heard in medical research. Your journey through prostate health and clinical trials is unique. Understanding PSA, breaking stigmas, ensuring diversity in clinical trials, ...

Catch up on all the notable drug and device approvals in urology over the past year.